# Melanoma cancer vaccine shows promise in late-stage clinical trial

https://mins.news/en/video/27811

- Global News, 2026-08-20 22:17 UTC
- Health
- Original: https://www.youtube.com/watch?v=hrkNQNJvv6c

> A new melanoma vaccine is producing promising results in a late-stage trial. The treatment combines immunotherapy with mRNA technology, using mutations identified in tumor cells removed during surgery to create a personalized vaccine designed to generate more cancer-fighting immune cells.

## Related coverage

- [Merck and Moderna’s personalized cancer vaccine success opens new melanoma treatment avenue](https://mins.news/en/item/28563) — CNN, 2026-08-21
- [‘Just the start of a wave’: The promise of mRNA cancer vaccines](https://mins.news/en/video/28303) — CNA, 2026-08-21
- [Personalized mRNA cancer vaccine shows promise](https://mins.news/en/video/26585) — ABC News, 2026-08-19
- [Moderna and Merck Revive mRNA Hopes With Melanoma Trial Success](https://mins.news/en/item/26437) — Bloomberg News, 2026-08-19
- [Moderna-Merck combination succeeds in late-stage skin cancer trial](https://mins.news/en/item/26142) — CNN, 2026-08-19